Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 8081018, 10 pages
https://doi.org/10.1155/2018/8081018
Research Article

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center

1Cancer Treatment Centers of America, Atlanta, GA, USA
2Jackson Memorial Hospital, Miami, FL, USA
3Sylvester Comprehensive Cancer Center, Miami, FL, USA
4Miller School of Medicine, University of Miami, Miami, FL, USA
5University of Miami Health System, Miami, FL, USA

Correspondence should be addressed to D. M. Hansra; moc.liamg@arsnahmd

Received 5 October 2017; Revised 28 December 2017; Accepted 4 January 2018; Published 12 April 2018

Academic Editor: Konrad Urech

Copyright © 2018 D. M. Hansra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Dunn, H. E. Cannon, T. Lewis, and L. Shane-McWhorter, “Development of a complementary and alternative medicine (CAM) pharmacy and therapeutics (P&T) subcommittee and CAM guide for providers.,” Journal of managed care pharmacy : JMCP, vol. 11, no. 3, pp. 252–258, 2005. View at Google Scholar · View at Scopus
  2. D. Kwan, K. Hirschkorn, and H. Boon, “U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: A systematic review,” BMC Complementary and Alternative Medicine, vol. 6, article no. 31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. McHuges and B. N. Timmermann, “A Review of the Use of CAM Therapy and the Sources of Accurate and Reliable Information,” Journal of Managed Care Pharmacy, vol. 11, no. 8, pp. 695–703, 2005. View at Publisher · View at Google Scholar
  4. P. Gardiner, R. S. Phillips, K. J. Kemper, A. Legedza, S. Henlon, and A. D. Woolf, “Dietary supplements: Inpatient policies in US children's hospitals,” Pediatrics, vol. 121, no. 4, pp. e775–e781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. “Most doctors not knowledgeable about herbals HealthDay News April 2010,” http://www.modernmedicine.com/%5Bnode-source-domain-raw%5D/news/clinical/clinical-pharmacology/most-doctors-not-knowledgeable-about-he.
  6. S. A. Waldman and A. Terzic, Pharmacology and Therapeutics: Principles to Practice, W. B. Saunders, Ed., Elsevier, Philadelphia, 2008.
  7. D. J. Kroll, “American Society of Health-System Pharmacists ASHP statement on the use of dietary supplements,” Am J Health Syst Pharm, vol. 61, pp. 1707–1711, 2004. View at Google Scholar
  8. L. G. Miller, A. Hume, I. M. Harris et al., “White paper on herbal products,” Pharmacotherapy, vol. 20, no. 7 I, pp. 877–891, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. “Federation of State Medical Boards (FSMB) Model Guidelines for the Use of Complementary and Alternative Medicine in Medical Practice April 2002,” http://www.fsmb.org/globalassets/advocacy/policies/model-guidelines-for-the-use-of-complementary-and-alternative-therapies-in-medical-practice.pdf.
  10. V. S. Cowen and V. Cyr, “Complementary and alternative medicine in US medical schools,” Advances in Medical Education and Practice, vol. 2015, no. 6, pp. 113–117, 2015. View at Publisher · View at Google Scholar
  11. L. Buffart, “Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs,” Cancer treatment reviews, vol. 52, pp. 91–104, 2017. View at Google Scholar
  12. J. C. Brown, T. B. Huedo-Medina, L. S. Pescatello, S. M. Pescatello, R. A. Ferrer, and B. T. Johnson, “Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis,” Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 1, pp. 123–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. I. Mishra, R. W. Scherer, P. M. Geigle et al., “Exercise interventions on health-related quality of life for cancer survivors,” Cochrane Database of Systematic Reviews, vol. 8, Article ID CD007566, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Speck, K. S. Courneya, L. C. Mâsse, S. Duval, and K. H. Schmitz, “An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis,” Journal of Cancer Survivorship, vol. 4, no. 2, pp. 87–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Demark-Wahnefried and L. W. Jones, “Promoting a Healthy Lifestyle Among Cancer Survivors,” Hematology/Oncology Clinics of North America, vol. 22, no. 2, pp. 319–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Ferrer, T. B. Huedo-Medina, B. T. Johnson, S. Ryan, and L. S. Pescatello, “Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes,” Annals of Behavioral Medicine, vol. 41, no. 1, pp. 32–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Y. T. Fong, J. W. C. Ho, and B. P. H. Hui, “Physical activity for cancer survivors: meta-analysis of randomised controlled trials,” British Medical Journal, vol. 344, article e70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Gardner, P. M. Livingston, and S. F. Fraser, “Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: A systematic review,” Journal of Clinical Oncology, vol. 32, no. 4, pp. 335–346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. I. Mishra, R. W. Scherer, C. Snyder, P. Geigle, and C. Gotay, “Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis,” Oncology Nursing Forum, vol. 41, no. 6, pp. E326–E342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Rock, C. Doyle, W. Demark-Wahnefried et al., “Nutrition and physical activity guidelines for cancer survivors,” CA: A Cancer Journal for Clinicians, vol. 62, no. 4, pp. 242–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. H. Schmitz, K. S. Courneya, and C. Matthews, “Erratum: American college of sports medicine roundtable on exercise guidelines for cancer survivors (Medicine and Science in Sports and Exercise (2010) 42: 7 (1409-1426)),” Medicine & Science in Sports & Exercise, vol. 43, no. 1, p. 195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Meneses-Echávez, E. González-Jiménez, and R. Ramírez-Vélez, “Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis,” BMC Cancer, vol. 15, p. 77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Dennett, C. L. Peiris, N. Shields, L. A. Prendergast, and N. F. Taylor, “Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: A systematic review and meta-regression,” Journal of Physiotherapy, vol. 62, no. 2, pp. 68–82, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. K. M. Mustian, C. M. Alfano, C. Heckler et al., “Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: A meta-analysis,” JAMA Oncology, vol. 3, no. 7, pp. 961–968, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. L. W. Jones and C. M. Alfano, “Exercise-oncology research: Past, present, and future,” Acta Oncologica, vol. 52, no. 2, pp. 195–215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Arem, R. M. Pfeiffer, E. A. Engels et al., “Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the national institutes of health-AARP diet and health study,” Journal of Clinical Oncology, vol. 33, no. 2, pp. 180–188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Arem, S. C. Moore, A. Patel et al., “Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship,” JAMA Internal Medicine, vol. 175, no. 6, pp. 959–967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Betof, M. W. Dewhirst, and L. W. Jones, “Effects and potential mechanisms of exercise training on cancer progression: A translational perspective,” Brain, Behavior, and Immunity, vol. 30, pp. S75–S87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. K. S. Courneya, C. M. Sellar, C. Stevinson et al., “Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients,” Journal of Clinical Oncology, vol. 27, no. 27, pp. 4605–4612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. Ibrahim and A. Al-Homaidh, “Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies,” Medical Oncology, vol. 28, no. 3, pp. 753–765, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Kenfield, M. J. Stampfer, E. Giovannucci, and J. M. Chan, “Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study,” Journal of Clinical Oncology, vol. 29, no. 6, pp. 726–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. L. N. Kohler, D. O. Garcia, R. B. Harris, E. Oren, D. J. Roe, and E. T. Jacobs, “Adherence to diet and physical activity cancer prevention guidelines and cancer outcomes: A systematic review,” Cancer Epidemiology, Biomarkers & Prevention, vol. 25, no. 7, pp. 1018–1028, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. I. M. Lahart, G. S. Metsios, A. M. Nevill, and A. R. Carmichael, “Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies,” Acta Oncologica, vol. 54, no. 5, pp. 635–654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ligibel, “Lifestyle factors in cancer survivorship,” Journal of Clinical Oncology, vol. 30, no. 30, pp. 3697–3704, 2012. View at Publisher · View at Google Scholar
  35. J. A. Meyerhardt, D. Heseltine, D. Niedzwiecki et al., “Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803,” Journal of Clinical Oncology, vol. 24, no. 22, pp. 3535–3541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Meyerhardt, J. Ma, and K. S. Courneya, “Energetics in colorectal and prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 26, pp. 4066–4073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. C. Moore, I.-M. Lee, E. Weiderpass et al., “Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults,” JAMA Internal Medicine, vol. 176, no. 6, pp. 816–825, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Schmid and M. F. Leitzmann, “Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis,” Annals of Oncology, vol. 25, no. 7, Article ID mdu012, pp. 1293–1311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. P. T. Williams, “Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking,” International Journal of Cancer, vol. 135, no. 5, pp. 1195–1202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. P. T. Campbell, A. V. Patel, C. C. Newton, E. J. Jacobs, and S. M. Gapstur, “Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival,” Journal of Clinical Oncology, vol. 31, no. 7, pp. 876–885, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Ariza-García, N. Galiano-Castillo, I. Cantarero-Villanueva, C. Fernández-Lao, L. Díaz-Rodríguez, and M. Arroyo-Morales, “Influence of physical inactivity in psychophysiolocigal state of breast cancer survivors,” European Journal of Cancer Care, vol. 22, no. 6, pp. 738–745, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Biswas, P. I. Oh, G. E. Faulkner et al., “Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 162, no. 2, pp. 123–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. R. A. Cannioto, M. LaMonte, and K. B. Moysich, “Abstract B18: Prediagnostic physical inactivity and epithelial ovarian cancer risk and mortality: Evidence from the Ovarian Cancer Association Consortium.,” Clinical Cancer Research, vol. 22, no. 2 Supplement, pp. B18–B18, 2016. View at Publisher · View at Google Scholar
  44. S. M. George, C. M. Alfano, J. Groves et al., “Objectively measured sedentary time is related to quality of life among cancer survivors,” PLoS ONE, vol. 9, no. 2, Article ID e87937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. A. V. Patel, J. S. Hildebrand, P. T. Campbell et al., “Leisure-time spent sitting and site-specific cancer incidence in a large U.S. Cohort,” Cancer Epidemiology, Biomarkers & Prevention, vol. 24, no. 9, pp. 1350–1359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Schmid and M. F. Leitzmann, “Television viewing and time spent sedentary in relation to cancer risk: A meta-analysis,” Journal of the National Cancer Institute, vol. 106, no. 7, Article ID dju098, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Shen, W. Mao, T. Liu et al., “Sedentary behavior and incident cancer: A meta-analysis of prospective studies,” PLoS ONE, vol. 9, no. 8, Article ID e105709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. C. K. Blair, M. C. Morey, R. A. Desmond et al., “Light-intensity activity attenuates functional decline in older cancer survivors,” Medicine & Science in Sports & Exercise, vol. 46, no. 7, pp. 1375–1383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Lu and D. S. Rosenthal, “Acupuncture for cancer pain and related symptoms.,” Current Pain and Headache Reports, vol. 17, no. 3, p. 321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Eghbali, M. S. Yekaninejad, S. varaei, S. F. Jalalinia, M. A. Samimi, and K. Sa'atchi, “The effect of auricular acupressure on nausea and vomiting caused by chemotherapy among breast cancer patients,” Complementary Therapies in Clinical Practice, vol. 24, pp. 189–194, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Han, L. Wang, H. Zheng et al., “Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma,” BMC Cancer, vol. 17, no. 1, p. 40, 2017. View at Publisher · View at Google Scholar
  52. Adult Cancer Pain (Version 2.2016), “National Comprehensive Cancer Network,” 2017, https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.
  53. J. J. Mao, C. Stricker, J. Farrar et al., “A randomized trial of electro-acupuncture for arthralgia related to aromatase inhibitor use,” Eur J Cancer, vol. 50, no. 2, pp. 267–276, 2014. View at Publisher · View at Google Scholar
  54. T. Bao, L. Cai, C. Snyder et al., “Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms,” Cancer, vol. 120, no. 3, pp. 381–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Meng, Y. Zhang, A. Li et al., “The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy,” Brain Research, vol. 1414, pp. 58–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. National Comprehensive Cancer Network, “Antiemesis (Version 2.2016),” 2017, https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.
  57. X. Wu, V. C. Chung, E. P. Hui et al., “Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews,” Scientific Reports, vol. 5, no. 1, 2015. View at Publisher · View at Google Scholar
  58. M. K. Garcia, L. Cohen, M. Spano et al., “Inpatient Acupuncture at a Major Cancer Center. Integr Cancer Ther,” October-December, p. 1, 2016. View at Google Scholar
  59. D. Tas, D. Uncu, M. A. Sendur, N. Koca, and N. Zengin, “Acupuncture as a complementary treatment for cancer patients receiving chemotherapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 7, pp. 3139–3144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. F. A. Morschhauser, G. Cartron, and C. Thieblemont, “Systematic review of acupuncture in cancer care: a synthesis of the evidence,” Journal of Clinical Oncology, vol. 37, no. 7, pp. 952–960, 2013. View at Google Scholar
  61. D. O'Regan and J. Filshie, “Acupuncture and Cancer,” Acupuncture and Cancer. Auton Neruosci, vol. 152, no. 1-2, pp. 96–100, 2010. View at Google Scholar
  62. A. J. Cohen, A. Menter, and L. Hale, “Acupuncture: Role in comprehensive cancer care - A primer for the oncologist and review of the literature,” Integrative Cancer Therapies, vol. 4, no. 2, pp. 131–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Ma, M. Dong, K. Zhou, C. Mita, J. Liu, and P. M. Wayne, “Publication Trends in Acupuncture Research: A 20-Year Bibliometric Analysis Based on PubMed,” PLos One, vol. 11, no. 2, 2016. View at Google Scholar
  64. B. Oh, T. Eade, A. Kneebone et al., “Factors affecting whether or not cancer patients consider using acupuncture,” Accupunct Med, Article ID 011115, p. 2016, 2016. View at Google Scholar
  65. M. M. Stanczyk, “Music therapy in supportive cancer care,” Reports of Practical Oncology and Radiotherapy, vol. 16, no. 5, pp. 170–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. M. M. Richardson, A. E. Babiak-Vazquez, and M. A. Frenkel, “Music therapy in a comprehensive cancer center,” J Soc Integr Oncol, vol. 6, no. 2, pp. 76–81, 2008. View at Google Scholar
  67. M. S. Cepeda, D. B. Carr, J. Lau, and H. Alvarez, “Music for pain relief,” Cochrane Database of Systematic Reviews (Online), no. 2, p. CD004843, 2006. View at Google Scholar · View at Scopus
  68. H. Greenlee, L. G. Balneaves, L. E. Carlson et al., “Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer,” JNCI Monographs, vol. 2014, no. 50, pp. 346–358, 2014. View at Publisher · View at Google Scholar
  69. S. Kordovan, P. Preissler, A. Kamphausen, C. Bokemeyer, and K. Oechsle, “Prospective Study on Music Therapy in Terminally Ill Cancer Patients during Specialized Inpatient Palliative Care,” Journal of Palliative Medicine, vol. 19, no. 4, pp. 394–399, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Boehm, H. Cramer, T. Staroszynski, and T. Ostermann, “Arts therapies for anxiety, depression, and quality of life in breast cancer patients: A systematic review and meta-analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 103297, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. O. Olaku and J. D. White, “Herbal therapy use by cancer patients: a literature review on case reports,” European Journal of Cancer, vol. 47, no. 4, pp. 508–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Ben-Arye, S. Attias, T. Tadmor, and E. Schiff, “Herbs in hemato-oncological care: An evidence-based review of data on efficacy, safety, and drug interactions,” Leukemia & Lymphoma, vol. 51, no. 8, pp. 1414–1423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. T. D. Shanafelt, Y. K. Lee, T. G. Call et al., “Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies,” Leukemia Research, vol. 30, no. 6, pp. 707–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. H. D. Hoon, J. H. Jeong, and H. J. Kim, “Anti-proliferative and apoptosis induction activity of green tea polyphenols on human promyelocytic leukemia HL-60 cells,” Anticancer Reseach, vol. 29, no. 4, pp. 1417–1422, 2009. View at Google Scholar · View at Scopus
  75. Y. K. Lee, N. D. Bone, A. K. Strege, T. D. Shanafelt, D. F. Jelinek, and N. E. Kay, “VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia,” Blood, vol. 104, no. 3, pp. 788–794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. L.-Y. Khil, W. Kim, S. Lyu, W. B. Park, J.-W. Yoon, and H.-S. Jun, “Mechanisms involved in Korean mistletoe lectin-induced apoptosis of cancer cells,” World Journal of Gastroenterology, vol. 13, no. 20, pp. 2811–2818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Urech, A. Buessing, G. Thalmann, H. Schaefermeyer, and P. Heusser, “Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines,” Anticancer Reseach, vol. 26, no. 4 B, pp. 3049–3055, 2006. View at Google Scholar · View at Scopus
  78. U. Valentiner, U. Pfüller, C. Baum, and U. Schumacher, “The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro,” Toxicology, vol. 171, no. 2-3, pp. 187–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. S. R. Elluru, J.-P. D. Van Huyen, S. Delignat et al., “Antiangiogenic properties of Viscum album extracts are associated with endothelial cytotoxicity,” Anticancer Reseach, vol. 29, no. 8, pp. 2945–2950, 2009. View at Google Scholar · View at Scopus
  80. U. Elsässer-Beile, C. Leiber, U. Wetterauer et al., “Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer,” Anticancer Reseach, vol. 25, no. 6 C, pp. 4733–4736, 2005. View at Google Scholar · View at Scopus
  81. Mistletoe Extracts, Health Professional Version, PDQ Cancer Information Summaries, Bethesda, 2002.
  82. D. M. Hansra, O. Silva, A. Mehta, and E. Ahn, “Patient with Metastatic Breast Cancer Achieves Stable Disease for 5 Years on Graviola and Xeloda after Progressing on Multiple Lines of Therapy,” Advances in Breast Cancer Research, vol. 03, no. 03, pp. 84–87, 2014. View at Publisher · View at Google Scholar
  83. M. A. Horneber, G. Bueschel, R. Huber, K. Linde, and M. Rostock, “Mistletoe therapy in oncology.,” Cochrane Database of Systematic Reviews (Online), no. 2, p. CD003297, 2008. View at Google Scholar · View at Scopus
  84. G. S. Kienle and H. Kiene, “Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts,” European Journal of Medical Research, vol. 12, no. 3, pp. 103–119, 2007. View at Google Scholar · View at Scopus
  85. P. R. Bock, W. E. Friedel, J. Hanisch, M. Karasmann, and B. Schneider, “Efficacy and safety of long-term complementary treatment with standardized european mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma/results of a multicenter, comparative, epidemiological cohort study in Germany and Switzerland,” Arzneimittel-Forschung/Drug Research, vol. 54, no. 8, pp. 456–466, 2004. View at Google Scholar · View at Scopus
  86. G. S. Kienle and H. Kiene, “Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies,” Integrative Cancer Therapies, vol. 9, no. 2, pp. 142–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. G. S. Kienle, A. Glockmann, M. Schink, and H. Kiene, “Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research,” Journal of Experimental & Clinical Cancer Research, vol. 28, no. 1, article 79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. B. K. Piao, Y. X. Wang, G. R. Xie et al., “Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial,” Anticancer Reseach, vol. 24, no. 1, pp. 303–309, 2004. View at Google Scholar · View at Scopus
  89. S. M. Zick, M. T. Ruffin, J. Lee et al., “Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting,” Supportive Care in Cancer, vol. 17, no. 5, pp. 563–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. M. E. Levine, M. G. Gillis, S. Y. Koch, A. C. Voss, R. M. Stern, and K. L. Koch, “Protein and ginger for the treatment of chemotherapy-induced delayed nausea,” The Journal of Alternative and Complementary Medicine, vol. 14, no. 5, pp. 545–551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. W. Marx, K. Ried, A. L. McCarthy et al., “Ginger—Mechanism of action in chemotherapy-induced nausea and vomiting: A review,” Critical Reviews in Food Science and Nutrition, vol. 57, no. 1, pp. 141–146, 2017. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Linde, M. M. Berner, and L. Kriston, “St John's wort for major depression.,” Cochrane Database of Systematic Reviews (Online), no. 4, p. CD000448, 2008. View at Google Scholar · View at Scopus
  93. M. H. Pittler and E. Ernst, “Kava extract for treating anxiety.,” Cochrane Database of Systematic Reviews (Online), no. 1, p. CD003383, 2003. View at Google Scholar · View at Scopus
  94. S. Witte, D. Loew, and W. Gaus, “Meta-analysis of the efficacy of the acetonic kava-kava extract WS®1490 in patients with non-psychotic anxiety disorders,” Phytotherapy Research, vol. 19, no. 3, pp. 183–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg, “Herbal remedies in the United States: potential adverse interactions with anticancer agents,” Journal of Clinical Oncology, vol. 22, no. 12, pp. 2489–2503, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. D. L. Clouatre, “Kava kava: Examining new reports of toxicity,” Toxicology Letters, vol. 150, no. 1, pp. 85–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. W. K. Oh, P. W. Kantoff, V. Weinberg et al., “Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer,” Journal of Clinical Oncology, vol. 22, no. 18, pp. 3705–3712, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Ikezoe, S. Chen, T. Saito et al., “PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.,” International Journal of Oncology, vol. 23, no. 4, pp. 1203–1211, 2003. View at Google Scholar · View at Scopus
  99. M. Shabbir, J. Love, and B. Montgometry, “Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer,” Oncology Reports, vol. 19, no. 3, pp. 831–835, 2008. View at Google Scholar · View at Scopus
  100. M. C. Weinrobe and B. Montgomery, “Acquired bleeding diathesis in a patient taking PC-SPES [4],” The New England Journal of Medicine, vol. 345, no. 16, pp. 1213-1214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Inoue-Choi, H. Greenlee, S. J. Oppeneer, and K. Robien, “The association between postdiagnosis dietary supplement use and total mortality differs by diet quality among older female cancer survivors,” Cancer Epidemiology, Biomarkers & Prevention, vol. 23, no. 5, pp. 865–875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. C. M. Velicer and C. M. Ulrich, “Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review,” Journal of Clinical Oncology, vol. 26, no. 4, pp. 665–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. G. M. John, D. L. Hershman, L. Falci, Z. Shi, W.-Y. Tsai, and H. Greenlee, “Complementary and alternative medicine use among US cancer survivors,” Journal of Cancer Survivorship, vol. 10, no. 5, pp. 850–864, 2016. View at Publisher · View at Google Scholar · View at Scopus
  104. P. A. Cohen, G. Maller, R. DeSouza, and J. Neal-Kababick, “Presence of banned drugs in dietary supplements following FDA recalls,” Journal of the American Medical Association, vol. 312, no. 16, pp. 1691–1693, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Carroll, K. Cooper, D. Papaioannou, D. Hind, H. Pilgrim, and P. Tappenden, “Supplemental calcium in the chemoprevention of colorectal cancer: A systematic review and meta-analysis,” Clinical Therapeutics, vol. 32, no. 5, pp. 789–803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. H. R. Harris, N. Orsini, and A. Wolk, “Vitamin C and survival among women with breast cancer: A Meta-analysis,” European Journal of Cancer, vol. 50, no. 7, pp. 1223–1231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. S. M. Sagar, T. Dryden, and R. K. Wong, “Massage therapy for cancer patients: A reciprocal relationship between body and mind,” Current Oncology, vol. 14, no. 2, pp. 45–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. B. R. Cassileth and A. J. Vickers, “Massage therapy for symptom control: outcome study at a major cancer center,” Journal of Pain and Symptom Management, vol. 28, no. 3, pp. 244–249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Billhult, I. Bergbom, and E. Stener-Victorin, “Massage relieves nausea in women with breast cancer who are undergoing chemotherapy,” The Journal of Alternative and Complementary Medicine, vol. 13, no. 1, pp. 53–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Listing, A. Reißhauer, M. Krohn et al., “Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer,” Psycho-Oncology, vol. 18, no. 12, pp. 1290–1299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Listing, M. Krohn, C. Liezmann et al., “The efficacy of classical massage on stress perception and cortisol following primary treatment of breast cancer,” Archives of Women's Mental Health, vol. 13, no. 2, pp. 165–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Hernandez-Reif, G. Ironson, T. Field et al., “Breast cancer patients have improved immune and neuroendocrine functions following massage therapy,” Journal of Psychosomatic Research, vol. 57, no. 1, pp. 45–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Krohn, M. Listing, G. Tjahjono et al., “Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy,” Supportive Care in Cancer, vol. 19, no. 9, pp. 1303–1311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Q. Pan, K. H. Yang, Y. L. Wang, L. P. Zhang, and H. Q. Liang, “Massage interventions and treatment-related side effects of breast cancer: a systematic review and meta-analysis,” International Journal of Clinical Oncology, vol. 19, no. 5, pp. 829–841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. E.-S. Shin, K.-H. Seo, S.-H. Lee et al., “Massage with or without aromatherapy for symptom relief in people with cancer,” Cochrane Database of Systematic Reviews, vol. 2016, no. 6, Article ID CD009873, 2016. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Wilkinson, K. Barnes, and L. Storey, “Massage for symptom relief in patients with cancer: Systematic review,” Journal of Advanced Nursing, vol. 63, no. 5, pp. 430–439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. J. J. Mao, K. E. Wagner, C. M. Seluzicki et al., “Integrating oncology massage into chemoinfusion suites: A program evaluation,” Journal of Oncology Practice, vol. 13, no. 3, pp. e207–e216, 2017. View at Publisher · View at Google Scholar · View at Scopus
  118. J. L. C. Lee, L. P. Leong, and S. L. Lim, “Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review,” Supportive Care in Cancer, vol. 24, no. 1, pp. 469–480, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Sánchez-Lara, J. G. Turcott, E. Juárez et al., “Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study,” Nutrition and Cancer, vol. 64, no. 4, pp. 526–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. M. D. D. S. Costa, C. Y. S. Vieira de Melo, A. C. R. D. Amorim, D. D. O. Cipriano Torres, and A. C. O. dos Santos, “Association Between Nutritional Status, Inflammatory Condition, and Prognostic Indexes with Postoperative Complications and Clinical Outcome of Patients with Gastrointestinal Neoplasia,” Nutrition and Cancer, vol. 68, no. 7, pp. 1108–1114, 2016. View at Publisher · View at Google Scholar · View at Scopus
  121. S. L. Hofbauer, A. J. Pantuck, M. de Martino et al., “The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma,” Urologic Oncology: Seminars and Original Investigations, vol. 33, no. 2, pp. 68.e1–68.e7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. N. Jiang, J.-Y. Deng, X.-W. Ding et al., “Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer,” World Journal of Gastroenterology, vol. 20, no. 30, pp. 10537–10544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. R. C. R. Albuquerque, V. T. Baltar, and D. M. L. Marchioni, “Breast cancer and dietary patterns: A systematic review,” Nutrition Reviews, vol. 72, no. 1, pp. 1–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. P. Bertuccio, V. Rosato, A. Andreano et al., “Dietary patterns and gastric cancer risk: A systematic review and meta-analysis,” Annals of Oncology, vol. 24, no. 6, pp. 1450–1458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. O. Oyebode, V. Gordon-Dseagu, A. Walker, and J. S. Mindell, “Fruit and vegetable consumption and all-cause, cancer and CVD mortality: analysis of health survey for England data,” Journal of Epidemiology and Community Health, vol. 68, no. 9, pp. 856–862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. J. A. Meyerhardt, D. Niedzwiecki, D. Hollis et al., “Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer,” Journal of the American Medical Association, vol. 298, no. 7, pp. 754–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. J. A. Meyerhardt, K. Sato, D. Niedzwiecki et al., “Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803,” Journal of the National Cancer Institute, vol. 104, no. 22, pp. 1702–1711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. M. L. McCullough, S. M. Gapstur, R. Shah, E. J. Jacobs, and P. T. Campbell, “Association between red and processed meat intake and mortality among colorectal cancer survivors,” Journal of Clinical Oncology, vol. 31, no. 22, pp. 2773–2782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. G.-C. Chen, X. Tong, J.-Y. Xu et al., “Whole-grain intake and total, cardiovascular, and cancer mortality: A systematic review and meta-analysis of prospective studies,” American Journal of Clinical Nutrition, vol. 104, no. 1, pp. 164–172, 2016. View at Publisher · View at Google Scholar · View at Scopus
  130. H.-J. Jia, P.-J. Zhang, Y.-L. Liu, C.-G. Jiang, X. Zhu, and Y.-P. Tian, “Relationship of serum polyunsaturated fatty acids with cytokines in colorectal cancer,” World Journal of Gastroenterology, vol. 22, no. 8, pp. 2524–2532, 2016. View at Publisher · View at Google Scholar · View at Scopus
  131. Y.-J. Ma, J. Yu, J. Xiao, and B.-W. Cao, “The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: A systematic evaluation,” Nutrition and Cancer, vol. 67, no. 1, pp. 112–118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  132. E. Toledo, J. Salas-Salvado, C. Donat-Vargas et al., “Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the predimed trial a randomized clinical trial,” JAMA Internal Medicine, vol. 175, no. 11, pp. 1752–1760, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. D. S. M. Chan, A. R. Vieira, D. Aune et al., “Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies,” Annals of Oncology, vol. 25, no. 10, pp. 1901–1914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. J. J. Dignam, B. N. Polite, G. Yothers et al., “Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer,” Journal of the National Cancer Institute, vol. 98, no. 22, pp. 1647–1654, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. B. J. Caan, M. L. Kwan, X. O. Shu et al., “Weight change and survival after breast cancer in the after breast cancer pooling project,” Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 8, pp. 1260–1271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. J. M. Salsman, J. E. Pustejovsky, H. S. L. Jim et al., “A meta-analytic approach to examining the correlation between religion/spirituality and mental health in cancer,” Cancer, vol. 121, no. 21, pp. 3769–3778, 2015. View at Publisher · View at Google Scholar · View at Scopus
  137. K. M. Piderman, M. E. Johnson, M. H. Frost et al., “Spiritual quality of life in advanced cancer patients receiving radiation therapy,” Psycho-Oncology, vol. 23, no. 2, pp. 216–221, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Hematti, M. Baradaran-Ghahfarokhi, R. Khajooei-Fard, and Z. Mohammadi-Bertiani, “Spiritual Well-Being for Increasing Life Expectancy in Palliative Radiotherapy Patients: A Questionnaire-Based Study,” Journal of Religion and Health, vol. 54, no. 5, pp. 1563–1572, 2015. View at Publisher · View at Google Scholar · View at Scopus
  139. A.-L. Williams, J. Dixon, R. Feinn, and R. McCorkle, “Cancer family caregiver depression: Are religion-related variables important?” Psycho-Oncology, vol. 24, no. 7, pp. 825–831, 2015. View at Publisher · View at Google Scholar · View at Scopus
  140. S. Li, M. J. Stampfer, D. R. Williams, and T. J. Vanderweele, “Association of religious service attendance with mortality amongWomen,” JAMA Internal Medicine, vol. 176, no. 6, pp. 777–785, 2016. View at Publisher · View at Google Scholar · View at Scopus
  141. P.-J. Oh and S. H. Kim, “The effects of spiritual interventions in patients with cancer: A meta-analysis,” Oncology Nursing Forum, vol. 41, no. 5, pp. E290–E301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. C. L. Petersen, “Spiritual care of the child with cancer at the end of life: A concept analysis,” Journal of Advanced Nursing, vol. 70, no. 6, pp. 1243–1253, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. T. A. Balboni, L. C. Vanderwerker, S. D. Block et al., “Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 555–560, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. A. B. Astrow, A. Wexler, K. Texeira, M. Kai He, and D. P. Sulmasy, “Is failure to meet spiritual needs associated with cancer patients' perceptions of quality of care and their satisfaction with care?” Journal of Clinical Oncology, vol. 25, no. 36, pp. 5753–5757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. J. A. Schreiber and D. Y. Brockopp, “Twenty-five years later-what do we know about religion/spirituality and psychological well-being among breast cancer survivors? A systematic review,” Journal of Cancer Survivorship, vol. 6, no. 1, pp. 82–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. M. King, H. Llewellyn, B. Leurent et al., “Spiritual beliefs near the end of life: A prospective cohort study of people with cancer receiving palliative care,” Psycho-Oncology, vol. 22, no. 11, pp. 2505–2512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. B. McLaughlin, W. Yoo, J. D'Angelo et al., “It is out of my hands: How deferring control to God can decrease quality of life for breast cancer patients,” Psycho-Oncology, vol. 22, no. 12, pp. 2747–2754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  148. H. S. L. Jim, J. E. Pustejovsky, C. L. Park et al., “Religion, spirituality, and physical health in cancer patients: A meta-analysis,” Cancer, vol. 121, no. 21, pp. 3760–3768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  149. A. C. Sherman, T. V. Merluzzi, J. E. Pustejovsky et al., “A meta-analytic review of religious or spiritual involvement and social health among cancer patients,” Cancer, vol. 121, no. 21, pp. 3779–3788, 2015. View at Publisher · View at Google Scholar · View at Scopus
  150. J. M. Salsman, G. Fitchett, T. V. Merluzzi, A. C. Sherman, and C. L. Park, “Religion, spirituality, and health outcomes in cancer: A case for a meta-analytic investigation,” Cancer, vol. 121, no. 21, pp. 3754–3759, 2015. View at Publisher · View at Google Scholar · View at Scopus
  151. D. M. Hansra et al., “Evaluation of Hematology/Oncology Patient and Physician Expectations for Integrative Oncology at a Tertiary Care Center,” Journal of Clinical Oncology, vol. 34, no. 5, pp. 488–494, 2016. View at Publisher · View at Google Scholar